NeoNet offers execution in Swiss equities via virt-x

NeoNet, an international agency broker providing efficient electronic equity execution services for the institutional investor industry, today announced that it offers trading in Swiss blue chip stocks through its membership at virt-x.

  0 Be the first to comment

External

This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author.

virt-x is the home exchange for Swiss blue chip stocks, including Novartis, Roche, Nestle, UBS, Credit Suisse Group, Swiss Re, Zurich Financial Services and ABB. virt-x is the London based international arm of the SWX Group (the Swiss Exchange) and also offers direct, real-time access to trading in the constituents of all the major pan-European blue chip indices.

"The introduction of execution at virt-x through our own membership further strengthens our direct market access strategy and strengthens our execution offering by giving clients trading access to several interesting blue chips," said Staffan Persson, acting CEO of NeoNet.

virt-x's CEO, Peter Keller, said today: "I am delighted to welcome NeoNet to membership of virt-x, which furthers the international reach of virt-x. NeoNet is the first member to take advantage of virt-x's new direct FIX based connectivity."

Sponsored [Impact Study] 2024 Fraud Trends in Banking, Insurance, and Beyond

Comments: (0)

[Webinar] 2025 Fraud Trends: Synthetic Identity, AI and Incoming MandatesFinextra Promoted[Webinar] 2025 Fraud Trends: Synthetic Identity, AI and Incoming Mandates